...
首页> 外文期刊>Best practice & research:Clinical endocrinology & metabolism >Universal screening for thyroid disease SHOULD NOT be recommended before and during pregnancy
【24h】

Universal screening for thyroid disease SHOULD NOT be recommended before and during pregnancy

机译:在怀孕之前和期间,不应推荐用于甲状腺疾病的通用筛查

获取原文
获取原文并翻译 | 示例
           

摘要

Thyroid dysfunction in pregnancy is strongly associated with adverse maternal and foetal outcomes. The effects of treatment are less clear. There is ongoing discussion on whom to treat, when to treat and whether treatment is beneficial. Although universal screening for thyroid disease during pregnancy increases diagnosis and treatment of thyroid dysfunction, there is currently insufficient evidence demonstrating a positive effect of screening on maternal and foetal outcomes. We therefore, at present, recommend against universal screening for thyroid disease before and during pregnancy. (c) 2020 Elsevier Ltd. All rights reserved.
机译:妊娠期甲状腺功能异常与不良孕产妇和胎儿结局密切相关。治疗的效果不太清楚。关于治疗谁、何时治疗以及治疗是否有益,目前正在进行讨论。尽管妊娠期甲状腺疾病的普遍筛查增加了甲状腺功能障碍的诊断和治疗,但目前没有足够的证据表明筛查对母婴结局有积极影响。因此,我们目前建议不要在怀孕前和怀孕期间进行甲状腺疾病的普遍筛查。(c) 2020爱思唯尔有限公司版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号